Підписатись
Mark S. Butler
Mark S. Butler
MSBChem Consulting / Casual Academic, IMB, Uni of Qld
Підтверджена електронна адреса в uq.edu.au - Домашня сторінка
Назва
Посилання
Посилання
Рік
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
RC Coll, AAB Robertson, JJ Chae, SC Higgins, R Muñoz-Planillo, ...
Nature medicine 21 (3), 248-255, 2015
25582015
The role of natural product chemistry in drug discovery
MS Butler
Journal of natural products 67 (12), 2141-2153, 2004
22862004
Natural products to drugs: natural product-derived compounds in clinical trials
MS Butler
Natural product reports 25 (3), 475-516, 2008
11672008
Natural products to drugs: natural product derived compounds in clinical trials
MS Butler
Natural product reports 22 (2), 162-195, 2005
8222005
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
R Gordon, EA Albornoz, DC Christie, MR Langley, V Kumar, S Mantovani, ...
Science translational medicine 10 (465), eaah4066, 2018
6952018
Natural product and natural product derived drugs in clinical trials
MS Butler, AAB Robertson, MA Cooper
Natural product reports 31 (11), 1612-1661, 2014
6802014
Antibiotics in the clinical pipeline in 2013
MS Butler, MA Blaskovich, MA Cooper
The Journal of antibiotics 66 (10), 571-591, 2013
5792013
Natural products—the future scaffolds for novel antibiotics?
MS Butler, AD Buss
Biochemical pharmacology 71 (7), 919-929, 2006
5572006
Antibiotics in the clinical pipeline at the end of 2015
MS Butler, MAT Blaskovich, MA Cooper
The Journal of antibiotics 70 (1), 3-24, 2017
4252017
Antibiotics in the clinical pipeline in 2011
MS Butler, MA Cooper
The Journal of antibiotics 64 (6), 413-425, 2011
3532011
Glycopeptide antibiotics: back to the future
MS Butler, KA Hansford, MAT Blaskovich, R Halai, MA Cooper
The Journal of antibiotics 67 (9), 631-644, 2014
3492014
Antibiotics in the clinical pipeline in October 2019
MS Butler, DL Paterson
The Journal of antibiotics 73 (6), 329-364, 2020
2922020
Developments in glycopeptide antibiotics
MAT Blaskovich, KA Hansford, MS Butler, ZG Jia, AE Mark, MA Cooper
ACS infectious diseases 4 (5), 715-735, 2018
2672018
Analysis of the clinical antibacterial and antituberculosis pipeline
U Theuretzbacher, S Gottwalt, P Beyer, M Butler, L Czaplewski, ...
The Lancet Infectious Diseases 19 (2), e40-e50, 2019
2482019
Identification of chelerythrine as an inhibitor of BclXL function
SL Chan, MC Lee, KO Tan, LK Yang, ASY Lee, H Flotow, NY Fu, ...
Journal of Biological Chemistry 278 (23), 20453-20456, 2003
2342003
Analysis of the clinical pipeline of treatments for drug-resistant bacterial infections: despite progress, more action is needed
MS Butler, V Gigante, H Sati, S Paulin, L Al-Sulaiman, JH Rex, ...
Antimicrobial agents and chemotherapy 66 (3), e01991-21, 2022
2222022
Dragmacidins:  New Protein Phosphatase Inhibitors from a Southern Australian Deep-Water Marine Sponge, Spongosorites sp.
RJ Capon, F Rooney, LM Murray, E Collins, ATR Sim, JAP Rostas, ...
Journal of natural products 61 (5), 660-662, 1998
2001998
An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria
AG Elliott, JX Huang, S Neve, J Zuegg, IA Edwards, AK Cain, CJ Boinett, ...
Nature communications 11 (1), 3184, 2020
1492020
Circumdatin G, a New Alkaloid from the Fungus Aspergillus ochraceus
JR Dai, BK Carté, PJ Sidebottom, AL Sek Yew, SB Ng, Y Huang, ...
Journal of natural products 64 (1), 125-126, 2001
1492001
Activity and predicted nephrotoxicity of synthetic antibiotics based on polymyxin B
A Gallardo-Godoy, C Muldoon, B Becker, AG Elliott, LH Lash, JX Huang, ...
Journal of medicinal chemistry 59 (3), 1068-1077, 2016
1482016
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20